Protective Efficacy of Flublok® Quadrivalent Versus Licensed Inactivated Influenza Vaccine in Adults ≥50 Years of Age

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The goal of this study is to establish that Flublok Quadrivalent is non-inferior to fully licensed (traditional approval status) quadrivalent inactivated influenza vaccine (IIV4) in protecting against laboratory-confirmed clinical influenza disease in the ≥50 year age population.
Epistemonikos ID: fbd8fa6f929b0e977f12edf48a77372383be68f7
First added on: May 12, 2024